Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bemnifosbuvir hemisulfate (AT-527) is a potent inhibitor of HCV virus replication.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 115.00 | |
5 mg | In stock | $ 247.00 | |
10 mg | In stock | $ 413.00 | |
25 mg | In stock | $ 692.00 | |
50 mg | In stock | $ 985.00 | |
100 mg | In stock | $ 1,330.00 |
Description | Bemnifosbuvir hemisulfate (AT-527) is a potent inhibitor of HCV virus replication. |
Targets&IC50 | SARS-CoV-2:0.47μM(EC90), HCV:5-28nM |
In vitro | The potent in vitro activity of AT-511, the free base of bemnifosbuvir hemisulfate, against several coronaviruses, including SARS-CoV-2. In normal human airway epithelial cells, the concentration of AT-511 required to inhibit replication of SARS-CoV-2 by 90% (EC90) was 0.47?μM, very similar to its EC90 against human coronavirus (HCoV)-229E, HCoV-OC43, and SARS-CoV in Huh-7 cells[1]. |
In vivo | When given orally to rats and monkeys, bemnifosbuvir hemisulfate preferentially delivered high levels of AT-9010 in the liver in vivo.These favorable preclinical attributes support bemnifosbuvir hemisulfate may increase SVR rates[2]. |
Synonyms | AT-527 |
Molecular Weight | 1261.15 |
Formula | C48H68F2N14O18P2S |
CAS No. | 2241337-84-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 170 mg/mL (269.60 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bemnifosbuvir hemisulfate 2241337-84-6 Microbiology/Virology Proteases/Proteasome HCV Protease SARS-CoV Inhibitor antiviral phosphoramidate HCV AT-527 nucleotide Bemnifosbuvir pangenotypic AT 527 Bemnifosbuvir Hemisulfate guanosine SARS coronavirus AT527 Hepatitis C virus inhibit inhibitor